Recombinant multi-species GCLC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GCLC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010]
The Alternative Names of target: CNSHA7,D9Wsu168e,GCL,GCLC,GCS,GCS heavy chain,GLCL,GLCL-H,GLCLC,Gamma-ECS,Gamma-glutamylcysteine synthetase,Gclc,Ggcs-hs,Glclc,Glutamate--cysteine ligase catalytic subunit

Target products collectionGo to GCLC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0890-Ag-1/ GM-Tg-hg-IP0890-Ag-2 Human GCLC protein Human
GM-Tg-rg-IP0890-Ag-1/ GM-Tg-rg-IP0890-Ag-2 Rat GCLC protein Rat
GM-Tg-mg-IP0890-Ag-1/ GM-Tg-mg-IP0890-Ag-2 Mouse GCLC protein Mouse
GM-Tg-cynog-IP0890-Ag-1/ GM-Tg-cynog-IP0890-Ag-2 Cynomolgus/Rhesus macaque GCLC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0890-Ag-1/ GM-Tg-felg-IP0890-Ag-2 Feline GCLC protein Feline
GM-Tg-cang-IP0890-Ag-1/ GM-Tg-cang-IP0890-Ag-2 Canine GCLC protein Canine
GM-Tg-bovg-IP0890-Ag-1/ GM-Tg-bovg-IP0890-Ag-2 Bovine GCLC protein Bovine
GM-Tg-equg-IP0890-Ag-1/ GM-Tg-equg-IP0890-Ag-2 Equine GCLC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0890-Ag-1/ GM-Tg-hg-IP0890-Ag-2; GM-Tg-rg-IP0890-Ag-1/ GM-Tg-rg-IP0890-Ag-2;
GM-Tg-mg-IP0890-Ag-1/ GM-Tg-mg-IP0890-Ag-2; GM-Tg-cynog-IP0890-Ag-1/ GM-Tg-cynog-IP0890-Ag-2;
GM-Tg-felg-IP0890-Ag-1/ GM-Tg-felg-IP0890-Ag-2; GM-Tg-cang-IP0890-Ag-1/ GM-Tg-cang-IP0890-Ag-2;
GM-Tg-bovg-IP0890-Ag-1/ GM-Tg-bovg-IP0890-Ag-2; GM-Tg-equg-IP0890-Ag-1/ GM-Tg-equg-IP0890-Ag-2
Products Name GCLC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GCLC
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GCLC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.